COVID-19 VACCINE MANUFACTURE; A REVELATION OF DEEP CRACKS IN THE INTERNATIONAL PATENT SYSTEM

The key question that COVID-19 has brought to the fore is that if biopharmaceutical patentees have disclosed their inventions as required by law, why are third-party manufacturers unable to manufacture these vaccines leading to uneven distribution of vaccines around the world?